RAD­HI­CA DE SIL­VA

Se­nior Mul­ti­me­dia Re­porter

rad­hi­ca.sookraj@guardian.co.tt

Can­cer sur­vivor Chloe Ram­nar­ine has suc­cess­ful­ly se­cured all the funds need­ed for her post-trans­plant care and will no longer re­quire pub­lic do­na­tions, her fam­i­ly has con­firmed.

In a mes­sage shared with Guardian Me­dia, Ram­nar­ine’s moth­er, Thilly­er Ram­nar­ine, said, “Thank­ful­ly, we have gath­ered enough fi­nances for Chloe’s post-care and as such don’t need any more fi­nan­cial help at this time. We kind­ly ask that this up­date be shared with the pub­lic … We are tru­ly grate­ful for every­thing that you’ve done and we are tru­ly hum­bled to­wards the pub­lic for all the help.”

The up­date comes months af­ter Ram­nar­ine un­der­went a bone mar­row trans­plant to treat stage 2B Hodgkin’s Lym­phoma. Ram­nar­ine was di­ag­nosed in ear­ly 2023 and had to pause her com­put­er sci­ence stud­ies at the Uni­ver­si­ty of the West In­dies to raise $980,000 for her treat­ment in Colom­bia.

The trans­plant was com­plet­ed on May 12 at Fun­da­cion San­ta Fe Hos­pi­tal. Fol­low­ing the pro­ce­dure, Ram­nar­ine was kept in the in­ten­sive care unit un­til her blood counts im­proved. She was dis­charged from hos­pi­tal on May 27.

Doc­tors have pre­scribed month­ly dos­es of Bren­tux­imab, a can­cer-fight­ing drug cost­ing US$3,000 per dose, to pre­vent re­lapse.
The fam­i­ly had been ex­plor­ing op­tions to se­cure Bren­tux­imab lo­cal­ly to re­duce on­go­ing trav­el and treat­ment costs.

With their fundrais­ing ef­forts now com­plete, the fam­i­ly has re­quest­ed that the pub­lic kind­ly re­frain from mak­ing any fur­ther do­na­tions, in ac­cor­dance with the terms of their fundrais­ing per­mit and bank­ing reg­u­la­tions.